Literature DB >> 25651364

Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.

Markus Ketteler1, Grahame J Elder2, Pieter Evenepoel3, Joachim H Ix4, Sophie A Jamal5, Marie-Hélène Lafage-Proust6, Rukshana Shroff7, Ravi I Thadhani8, Marcello A Tonelli9, Bertram L Kasiske10, David C Wheeler11, Mary B Leonard12.   

Abstract

A new definition and classification of chronic kidney disease-mineral and bone disorder (CKD-MBD) was proposed in 2005 and it was later followed by a guideline publication on this topic from Kidney Disease: Improving Global Outcomes (KDIGO) in 2009. This work recognized that CKD-MBD is a syndrome of bone abnormalities, laboratory abnormalities, and vascular calcification linked to fractures, cardiovascular disease, and mortality. Because of limited data at the time of the original guideline systematic review, many of the recommendations were cautiously vague. KDIGO convened a Controversies Conference in October 2013 to review the CKD-MBD literature published since the 2009 guideline. Specifically, the objective of this conference was to determine whether sufficient new data had emerged to support a reassessment of the CKD-MBD guideline and if so to determine the scope of these potential revisions. This report summarizes the results of these proceedings, highlighting important new studies conducted in the interval since the original KDIGO CKD-MBD guideline.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25651364     DOI: 10.1038/ki.2014.425

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  38 in total

1.  Safety and efficacy of denosumab in osteoporotic hemodialysed patients.

Authors:  Francescaromana Festuccia; Maryam Tayefeh Jafari; Alessandra Moioli; Claudia Fofi; Simona Barberi; Stefano Amendola; Salvatore Sciacchitano; Giorgio Punzo; Paolo Menè
Journal:  J Nephrol       Date:  2016-07-09       Impact factor: 3.902

Review 2.  Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease.

Authors:  Ziad Massy; Tilman Drueke
Journal:  J Nephrol       Date:  2017-04-12       Impact factor: 3.902

Review 3.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

4.  An introduction to CKD-MBD research: restart for the future.

Authors:  Masafumi Fukagawa; Masaaki Inaba; Keitaro Yokoyama; Takashi Shigematsu; Ryoichi Ando; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2017-03       Impact factor: 2.801

5.  The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.

Authors:  J Aleksova; S Kurniawan; G J Elder
Journal:  Osteoporos Int       Date:  2018-03-19       Impact factor: 4.507

Review 6.  Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Authors:  Jordi Bover; Lucía Bailone; Víctor López-Báez; Silvia Benito; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  J Nephrol       Date:  2017-04-21       Impact factor: 3.902

Review 7.  The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.

Authors:  Martin Jannot; Fabrice Mac-Way; Vanessa Lapierre; Marie-Helene Lafage-Proust
Journal:  J Nephrol       Date:  2017-09-12       Impact factor: 3.902

Review 8.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

9.  Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients.

Authors:  Maria Fusaro; Maurizio Gallieni; Paola Rebora; Maria Antonietta Rizzo; Maria Carmen Luise; Hilary Riva; Silvio Bertoli; Ferruccio Conte; Andrea Stella; Patrizia Ondei; Emanuela Rossi; Maria Grazia Valsecchi; Antonio Santoro; Simonetta Genovesi
Journal:  J Nephrol       Date:  2015-10-22       Impact factor: 3.902

Review 10.  Bone kidney interactions.

Authors:  Thomas L Nickolas; Sophie A Jamal
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.